- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
Hnrnpll Point Mutation Mice
| Strain Name | Hnrnpll Point Mutation (M01043) |
|---|---|
| Editing Type | Point mutation (knockin) |
| Gene Name | *Hnrnpll* (heterogeneous nuclear ribonucleoprotein L-like; human ortholog HNRNPLL) |
| Gene Synonyms | Hnrpll; 2510028H02Rik; 2810036L13Rik |
| Strain Background | C57BL/6N |
| NCBI No. | Gene ID 72692 |

- RNA splicing & immune regulation — Study how hnRNPLL regulates alternative splicing in immune cells, particularly CD45 (Ptprc) variable exon 4 and its downstream effects on T cell surface receptor expression and function.
- T cell biology & immune tolerance — Assess the impact of hnRNPLL mutation on immune cell development, differentiation, and function; investigate how altered splicing programs perturb T cell activation and tolerance.
- Autoimmune mechanism modeling — Provide a defined genetic tool for dissecting the splicing-to-autoimmunity axis upstream of CD45 isoform imbalance, complementing CD45 mutant models.
- Drug discovery & target validation — Support screening and validation of compounds targeting RNA splicing regulation or hnRNPLL-related pathways.
This mouse strain is generated through gene editing technology to introduce a specific point mutation into the mouse Hnrnpll gene. HNRNPLL (heterogeneous nuclear ribonucleoprotein L-like) is an RNA-binding protein and a crucial splicing regulator, particularly in T cells where it represses the variable exons of Ptprc and thereby controls CD45 isoform switching. This model carries a defined point mutation rather than a null allele, preserving the protein scaffold while perturbing its splicing-regulatory function. It provides a research tool for in vivo investigation of how HNRNPLL dysfunction alters RNA splicing, remodels T cell transcriptomes, and contributes to loss of immune tolerance. It is suitable for research on autoimmune disease mechanisms, RNA biology, and immunometabolism.
- Point mutation, not a null allele — The protein scaffold is retained and only the defined residue is altered, allowing separation of splicing-regulatory function from complete protein loss.
- Direct CD45 (Ptprc) splicing readout — hnRNPLL is the signal-induced repressor of CD45 variable exon 4; the model gives a clean, quantifiable CD45RA/RO isoform endpoint.
- Memory T cell programming — The founding thunder allele was shown to program memory T cell RNA rearrangement, with a single substitution destabilizing the RNA-recognition domain.
- Captures CD45-independent functions — In T cells lacking CD45 protein, hnRNPLL mutation still diminishes peripheral T cell accumulation, so the model reveals CD45-independent control of T cell longevity.
- Extends beyond T cells — Documented roles in B cell-to-plasma cell differentiation and in CD44 alternative splicing during epithelial-mesenchymal transition support autoimmunity, plasma cell, and metastasis research on one strain.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.
